The 11 mm extruder is designed specifically for pharmaceutical applications to minimize material costs, be easier to use and optimize laboratory space.

To achieve this, the benchtop Pharma 11 uses a minimal amount of sample material (20 g) and features a user-friendly touchscreen with integrated feeder control.

To deliver performance as requested by today’s pharma developers, Thermo Fisher, for the first time, offers a complete strandline, containing air-cooled conveyor belt and adjustable pelletizer, all with the convenient footprint of a standard fumehood.

“Since its introduction six months ago, our customers have extensively tested Pharma 11 in real-life applications. And, time after time, researchers and scientists have confirmed the tagline ‘Small, Simple, Scalable’ in every aspect,” said Charndeep Khattar, Director product line Process/Pharma Instruments at Thermo Fisher.

Khattar continued, “With its compact footprint and minimal sample material use, Pharma 11 simplifies the testing process and enables scientists to focus on delivering world-class pharmaceutical research. It is no wonder that the number of Pharma 11 extruders deployed worldwide today has exceeded all expectations.”

The new Pharma 11 extruder features a throughput of 20 g/h to 2.5 kg/h and is easily convertible from hot melt extrusion (HME) to twin screw granulation (TSG) applications.

The Pharma 11 extruder is ideal for a wide range of drug development applications including drug delivery systems, implants, tablets and granules.

The GMP-compliant device is also suitable for clinical trials, and the compact design makes it ideal for glove box applications.

Thermo Fisher, one of the pioneers in rheology, successfully supports a wide range of industries with its comprehensive Thermo Scientific material characterization solutions.